Heterotopic bone formation around sintered porous-surfaced Ti-6Al-4V implants coated with native bone morphogenetic proteins

Implant Dentistry

Volumn 15, Issue 3, 2006, Pages 265-274

  Simon, Ziv ^a,b   Deporter, Douglas A ^c   Pilliar, Robert M ^c   Clokie, Cameron M ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b University of Toronto ^*

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone morphogenetic proteins; Dental implants; Osseointegration

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; HERBACEOUS AGENT; OSTEOKING; TITANIUM; TITANIUM ALLOY (TIAL6V4);

ANIMAL; ARTICLE; HETEROTOPIC OSSIFICATION; HUMAN; MALE; MOUSE; PROSTHESES AND ORTHOSES;

ANIMALS; BONE MORPHOGENETIC PROTEINS; COATED MATERIALS, BIOCOMPATIBLE; DRUGS, CHINESE HERBAL; HUMANS; MALE; MICE; OSSIFICATION, HETEROTOPIC; PROSTHESES AND IMPLANTS; TITANIUM;

EID: 33748706966     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000226754.71828.6b     Document Type: Article

References (48)

1. Raghoeba GM, Louwerse C, Kalk Wl, et al. Morbidity of chin bone harvesting. Clin Oral Implants Res. 2001;12:503-507.
2. Nkenke E, Schultze-Mosgau S, Radespiel-Troger M, et al. Morbidity of harvesting chin grafts: A prospective study. Clin Oral Implants Res. 2001;12:495-502.
3. Lekholm U, Zarb GA. Patient selection and preparation. In: Brånemark PI, Zarb GA, Albrektsson T, eds. Tissue Integrated Prostheses: Osseointegration in Clinical Dentistry. Chicago, IL Quintessence; 1985:199-209.
4. Davies JE. Mechanisms of endosseous integration. Int J Prosthodont. 1998;11:391-401.
5. Adell R, Lekholm U, Rockler B, et al. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg. 1981;10:387-416.
6. Murphy WL, Peters MC, Kohn DH, et al. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials. 2000;21:2521-2527
7. Vehof WM, Haus MT, de Ruijter AE, et al. Bone formation in transforming growth factor beta-1 -loaded titanium fiber mesh implants. Clin Oral Implants Res. 2002;13:94-102.
8. Lee SJ, Park YJ, Park SN, et al. Molded porous poly(L-lactide) membranes for guided bone regeneration with enhanced effects by controlled growth factor release. J Biomed Mater Res. 2001;55:295-303.
9. Lind M, Overgaard S, Soballe K, et al. Transforming growth factor-beta 1 enhances bone healing to unloaded triealcium phosphate coated implants: An experimental study in dogs. J Orthop Res. 1996;14:343-350.
10. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science. 1988;242:1528-1534.
11. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev. 1992;32:160-167.
12. Tickle C. Vertebrate development. On making a skeleton. Nature. 1994;368:587-588.
13. Duboule D. The vertebrate limb: A model system to study the Hox/HOM gene network during development and evolution. Bioassays. 1992;14:375-384.
14. Duboule D. How to make a limb? Science. 1994;266:575-576.
15. Winnier GM, Blessing PA, Labosky B, et al. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995;9: 2105-2116.
16. Kingsley DM. What do BMPs do in mammals? Clues from the mouse shortear mutation. Trends Genet. 1994;10:16-21.
17. Francis PH, Richardson MK, Brickell PM, et al. Bone morphogenetic proteins and a signaling pathway that controls patterning in the developing chick limb. Development. 1994;120:209-218.
18. Urist MR. Bone: Formation by autoinduction. Science. 1965;150:893-899.
19. Bessho K, Cames DL, Cavin R, et al. BMP stimulation of bone response adjacent to titanium implants in vivo. Clin Oral Implants Res. 1999;10:212-218.
20. Xiang WL, Baolin J, Yan J, et al. The effect of bone morphogenetic protein on osseointegration of titanium implants. J Oral Maxillofac Surg. 1993;51:647-651.
21. Rutherford RB, Sampath TK, Rueger DC, et al. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int J Oral Maxillofac Implants. 1992;7:297-301.
22. Yoshinari MY, Oda H, Ueki H, et al. Immobilization of bisphosphonates on surface modified titanium. Biomaterials. 2001;22:709-715.
23. Lind M, Overgaard S, Nguyen T, et al. Transforming growth factor-beta stimulates bone ingrowth. Hydroxyapatite-coated implants studied in dogs. Acta Orthop Scand. 1996;67:611-616.
24. Sumner DR, Turner TM, Purchio AF, et al. Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg Am. 1995;77:1135-1147.
25. Ripamonti U, Yeates L, van den Heever B. Initiation of heterotopic osteogenesis in primates after Chromatographic adsorption of osteogenin, a bone morphogenetic protein, onto porous hydroxyapatite. Biochem Biophys Res Commun. 1993;193:509-517.
26. Pilliar RM. Overview of surface variability of metallic endosseous dental implants: Textured and porous surface-structured designs. Implant Dent. 1998;7: 305-314.
27. Clokie CM, Urist MR. Bone morphogenetic protein excipients: Comparative observations on poloxamer. Plast Reconstr Surg. 2000;105:628-637.
28. Urist MR, Huo YK, Brownell AG, et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci USA. 1984;81:371-375.
29. Deporter DA, Watson PA, Pilliar RM, et al. A histological assessment of the initial healing response adjacent to poroussurfaced, titanium alloy dental implants in dogs. J Dent Res. 1986;65:1064-1070.
30. Deporter DA, Watson PA, Pilliar RM, et al. A histological comparison in the dog of porous-coated vs. threaded dental implants. J Dent Res. 1990;69:1138-1145.
31. Fowler EB, Cuenin MF, Hokett SD, et al. Evaluation of pluronic polyols as carriers for grafting materials: Study in rat calvaria defects. J Periodontol. 2002;73:191-197.
32. Becker W, Urist MR, Tucker LM, et al. Human demineralized freeze-dried bone formation in athymic mice. A preliminary report. J Periodontol. 1995;66:822-828.
33. Schwartz Z, Mellonig JT, Carnes DL, et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol. 1996;67:918-926.
34. Garraway R, Young WG, Daley T, et al. An assessment of the osteoinductive potential of commercial demineralized freeze-dried bone in the murine thigh muscle implantation model. J Periodontol. 1998;69:1325-1336.
35. Schwartz Z, Somers A, Mellonig JT, et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation is dependent on donor age but not gender. J Periodontol. 1998;69:470-478.
36. LJ H, Pujic Z, Xiao Y, et al. Identification of bone morphogenetic proteins 2 and 4 in commercial demineralized freeze-dried bone allograft preparations: Pilot study, Clin Implant Dent Relat Res. 2000;2:110-117.
37. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol. 1996;67:545-553.
38. Cochran DL, Schenk R, Buser D, et al. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol. 1999;70:139-150.
39. Cochran DL, Jones AA, Lilly LC, et al. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol. 2000;71:1241-1257.
40. Kusumoto K, Bessho K, Fujimura K, et al. Intramuscular osteoinduction and bone marrow formation by the implantation of rhBMP-2 with atelopeptide type I collagen. Br J Oral Maxillofac Surg. 1997;35:433-437.
41. Kusumoto K, Bessho K, Fujimura K, et al. Prefabricated muscle flap including bone induced by recombinant human bone morphogenetic protein-2: An experimental study of ectopic osteoinduction in a rat latissimus dorsi muscle flap. Br J Plast Surg. 1998;51:275-280.
42. Isobe M, Yamazaki Y, Mori M, et al. Bone regeneration produced in rat femur defects by polymer capsules containing recombinant human bone morphogenetic protein-2. J Oral Maxillofac Surg. 1999;57:695-698.
43. Alpaslan C, Irie K, Takahashi K, et al. Long-term evaluation of recombinant human bone morphogenetic protein-2 induced bone formation with a biologic and synthetic delivery system. Br J Oral Maxillofac Surg. 1996;34:414-418.
44. Okubo Y, Bessho K, Fujimura Y, et al. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, subcutaneous and intrafatty sites. Int J Oral Maxillofac Surg. 2000;29:62-66.
45. Tresguerres IF, Blanco L, Clem-ente C, et al. Effects of local administration of growth hormone in peri-implant bone: An experimental study with implants in rabbit tibiae. Int J Oral Maxillofac Implants. 2003;18:807-811.
46. Tache A, Gan L, Deporter DA, et al. Effect of surface chemistry on the rate of osseointegration of sintered poroussurfaced Ti-6Al-4V implants. Int J Oral Maxillofac Implants. 2004;19:19-29.
47. Talwar R, De Silvio L, Hughes FJ, et al. Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo. J Clin Periodontol. 2001;28:340-347.
48. Okubo Y, Bessho K, Fujimura K, et al. Expression of bone morphogenetic protein in the course of osteoinducrjon by recombinant human bone morphogenetic protein-2. Clin Oral Implants Res. 2002;13:80-85.